Abstract
You have accessJournal of UrologyCME1 May 2022MP29-08 AQUABLATION FOR BENIGN PROSTATIC HYPERPLASIA IN LARGE PROSTATES (80-150CC): 4-YEAR RESULTS Naeem Bhojani Naeem BhojaniNaeem Bhojani More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002572.08AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: To report 4-year safety and efficacy outcomes of the Aquablation procedure for the treatment of men with symptomatic benign prostatic hyperplasia (BPH) and large-volume prostates. METHODS: 101 men with moderate-to-severe BPH symptoms and prostate volumes between 80-150cc underwent robotically executed Aquablation in a prospective multicenter international clinical trial with scheduled follow-up at 5 years. Herein we report the 4 year data. RESULTS: Mean prostate volume was 107cc (range 80-150). Mean operative time, TRUS in to catheter in, was 55 minutes and mean Aquablation resection time was 8 minutes. IPSS scores improved from 23.2 at baseline to 5.6 at 4 years (change of -16.6 points, p<.0001). Qmax improved from 8.7 cc/sec at baseline to 18.2 cc/sec at 4 years. Improvements in both IPSS, IPSS Quality of Life, Qmax, and PVR were immediate and sustained throughout follow-up (Figure 1). At 4 years the retreatment rate was less than 1% per year. CONCLUSIONS: At 4-year prospective follow-up, the Aquablation procedure was shown to be safe and effective in men with large prostates (80-150cc). ClinicalTrials.gov number, NCT03123250.*Submitted on behave of the Water II investigators. Source of Funding: Procept Biorobotics © 2022 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 207Issue Supplement 5May 2022Page: e472 Advertisement Copyright & Permissions© 2022 by American Urological Association Education and Research, Inc.MetricsAuthor Information Naeem Bhojani More articles by this author Expand All Advertisement PDF DownloadLoading ...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.